Biocon Q4 net profit up 25%
Reuters | HT Correspondent, Bangalore
Apr 28, 2011 10:07 AM IST
Top-listed biotechnology firm Biocon Ltd today reported a 25% rise in fourth-quarter profit as strong sales of its biopharmaceutical drugs helped offset muted sales at its German unit.
Top-listed biotechnology firm Biocon Ltd on Thursday reported a 25% rise in fourth-quarter profit as strong sales of its biopharmaceutical drugs helped offset muted sales at its German unit.
Bangalore-based Biocon had in January said revenue from its German arm AxiCorp would be pressured as it eliminated some low-margin drugs from its portfolio after the German government asked drugmakers to offer a rebate.
Unlock exclusive access to the story of India's general elections, only on the HT App. Download Now!
For the quarter ended March, consolidated net profit rose to 1.01 billion rupees ($22.78 million) from 806 million rupees reported a year earlier.
Shares in Biocon, valued at $1.7 billion have fallen 8.4% this year, steeper than the wider market's 5% fall.
Discover the complete story of India's general elections on our exclusive Elections Product! Access all the content absolutely free on the HT App. Download now!
Stay informed on Business News, TCS Q4 Results Live along with Gold Rates Today, India News and other related updates on Hindustan Times Website and APPs
Stay informed on Business News, TCS Q4 Results Live along with Gold Rates Today, India News and other related updates on Hindustan Times Website and APPs
Share this article